Harven V. Deshield

Prior to his appointment as CEO, Dr. DeShield served as Chief Legal and Operations Officer of Vivacelle Bio, Inc. for four years. He is also a former ​​​Vice President of Commercialization and Business Development for a biomedical device company developing next-generation novel wound healing medical device technologies and therapies. His professional experiences have also encompassed developing and implementing corporate strategies and vetting and selection of preclinical assets for clinical and regulatory development for a biotech holding company focused exclusively on commercializing oncology assets.

Dr. DeShield is a pharmaceutical, biomedical, and life sciences intellectual property attorney with more than twelve years of experience. He has experience in fundraising, patent litigation, and prosecution, intellectual property transactions encompassing licensing and assignments of patents and trademarks, due diligence with respect to mergers and acquisitions, FDA law, contracts and business agreements, discovery, research and joint development collaborative agreements, joint venture and partnering agreements, service, manufacturing and quality control agreements, clinical trial agreements and confidentiality and non-disclosure agreements.

Dr. DeShield holds a doctorate in Biochemistry from SUNY, Buffalo School of Medicine and Biomedical Sciences, a Masters in Biological Sciences from SUNY, Buffalo Department of Biological Sciences, and a Juris Doctorate from SUNY, Buffalo Law School, with a concentration in Intellectual Property and Technology Law. He also holds a Bachelor of Science in Biology with honors from Appalachian State University in Boone, NC.